Product Description
Overall, the global off-pump coronary artery bypass device market was valued at $219 million in 2025. This is expected to decrease at a CAGR of –1.2% to $200 million over the forecast period.
The full report suite on the global market for off-pump coronary artery bypass (OPCAB) device includes positioner devices and stabilizer devices.
The report includes data for 65 countries across 7 different regions which include North America, Latin America, Western Europe, Central & Eastern Europe, Middle East, Asia-Pacific, and Africa.
Data Types Included
- Unit Sales, Average Selling Prices, Market Size & Growth Trends
- Procedure Numbers
- Market Drivers & Limiters
- Market Forecasts Until 2032, and Historical Data to 2022
- Recent Mergers & Acquisitions
- Company Profiles and Product Portfolios
- Leading Competitors
Off-Pump Coronary Artery Bypass Device Market Trends
The growing adoption of minimally invasive and robotic coronary artery bypass procedures is increasing demand for advanced off-pump coronary artery bypass (OPCAB) devices that support beating-heart techniques. Minimally invasive direct CABG and robotic-assisted approaches require precise stabilization and positioning of target coronary vessels through limited surgical access, placing greater emphasis on low-profile, highly maneuverable stabilizers and positioners. In response, device manufacturers are focusing on improving visibility, flexibility, and ease of use in constrained operative fields, supporting continued product innovation within this segment.
Off-Pump Coronary Artery Bypass Device Market Share Insights
- Medtronic was the leading competitor in the OPCAB market. For stabilizers, Medtronic offers its Octopus™ Evolution, Octopus™ 4 and Octopus™ 4.3 tissue stabilizers. The Starfish™ Evo, Starfish™ 2, Urchin™ and Urchin™ 2 complete Medtronic’s heart positioner product portfolio. Since Medtronic has left the ventricular assist device market, it is expected that it will expand its presence in the OPCAB segment.
- Getinge was the second-leading competitor in the global OPCAB market. Getinge offers its beating-heart stabilizers and positioners product portfolios. Getinge offers products across multiple segments and they have shifted investments to other segments. As the OPCAB market is on the decline, it is expected that the company will lose some market share in the coming years.
- Terumo captured the third-leading position in the total OPCAB market. The company’ Universal Stabilizer Arm™ introduced the concept of an articulating arm attached to a sternal retractor for cardiac surgery applications. With a unique and innovative product portfolio, Terumo is likely to gain greater presence in the OPCAB market over the forecast period.
Off-Pump Coronary Artery Bypass Device Market Segmentation Summary
- Off-Pump Coronary Artery Bypass Device Market – Further Segmented Into:
- Device Type: Stabilizer Devices, and Positioners.
Research Scope Summary
| Report Attribute | Details |
|---|---|
| Regions | North America (Canada, United States) Latin America (Argentina, Bolivia, Brazil, Chile, Colombia, Costa Rica, Dominican Republic, Ecuador, Guatemala, Mexico, Panama, Paraguay, Peru, Puerto Rico, Uruguay, Venezuela) Western Europe (Austria, Benelux, France, Germany, Italy, Portugal, Scandinavia, Spain, Switzerland, United Kingdom) Central & Eastern Europe (Azerbaijan, Baltic States, Belarus, Bulgaria, Croatia, Czech Republic, Georgia, Greece, Hungary, Kazakhstan, Poland, Romania, Russia, Serbia, Slovakia, Slovenia, Turkey, Ukraine) Middle East (Bahrain, Iran, Israel, Kuwait, Oman, Qatar, Saudi Arabia, United Arab Emirates) Asia Pacific (Australia, Cambodia, China, Hong Kong, India, Indonesia, Japan, Kyrgyzstan, Macao, Malaysia, Mongolia, Myanmar, New Zealand, Pakistan, Philippines, Singapore, South Korea, Sri Lanka, Taiwan, Thailand, Uzbekistan, Vietnam) Africa (Algeria, Egypt, Ethiopia, Ghana, Kenya, Libya, Morocco, Nigeria, South Africa, Sudan, Uganda) |
| Base Year | 2025 |
| Forecast | 2026-2032 |
| Historical Data | 2022-2024 |
| Quantitative Coverage | Market Size, Market Shares, Market Forecasts, Market Growth Rates, Units Sold, and Average Selling Prices. |
| Qualitative Coverage | Market Growth Trends, Market Limiters, Competitive Analysis & SWOT for Top Competitors, Mergers & Acquisitions, Company Profiles, Product Portfolios, FDA Recalls, Disruptive Technologies, Disease Overviews. |
| Data Sources | Primary Interviews with Industry Leaders, Government Physician Data, Regulatory Data, Hospital Private Data, Import & Export Data, iData Research Internal Database. |
CONTACT US FOR ADDITIONAL INFORMATION
For full segmentation and any questions regarding research coverage, please contact us for a complimentary demo of the full report.
